Ahn YM - Search Results

1

Oncogenic potential of histone-variant H2A.Z.1 and its regulatory role in cell cycle and epithelial-mesenchymal transition in liver cancer.

Yang HD, Kim PJ, Eun JW, Shen Q, Kim HS, Shin WC, Ahn YM, Park WS, Lee JY, Nam SW. Yang HD, et al. Among authors: ahn ym. Oncotarget. 2016 Mar 8;7(10):11412-23. doi: 10.18632/oncotarget.7194. Oncotarget. 2016. PMID: 26863632 Free PMC article.

2

Oncogenic potential of CK2α and its regulatory role in EGF-induced HDAC2 expression in human liver cancer.

Kim HS, Chang YG, Bae HJ, Eun JW, Shen Q, Park SJ, Shin WC, Lee EK, Park S, Ahn YM, Park WS, Lee JY, Nam SW. Kim HS, et al. Among authors: ahn ym. FEBS J. 2014 Feb;281(3):851-61. doi: 10.1111/febs.12652. FEBS J. 2014. PMID: 24616922 Free article.

3

Increased expression of histone deacetylase 2 is found in human gastric cancer.

Song J, Noh JH, Lee JH, Eun JW, Ahn YM, Kim SY, Lee SH, Park WS, Yoo NJ, Lee JY, Nam SW. Song J, et al. Among authors: ahn ym. APMIS. 2005 Apr;113(4):264-8. doi: 10.1111/j.1600-0463.2005.apm_04.x. APMIS. 2005. PMID: 15865607

4

Comparative analysis of expression profiling of early-stage carcinogenesis using nodule-in-nodule-type hepatocellular carcinoma.

Nam SW, Lee JH, Noh JH, Lee SN, Kim SY, Lee SH, Park CK, Ahn YM, Park WS, Yoo NJ, Lee JY. Nam SW, et al. Among authors: ahn ym. Eur J Gastroenterol Hepatol. 2006 Mar;18(3):239-47. doi: 10.1097/00042737-200603000-00003. Eur J Gastroenterol Hepatol. 2006. PMID: 16462536

5

Identification of large-scale molecular changes of Autotaxin(ENPP2) knock-down by small interfering RNA in breast cancer cells.

Noh JH, Ryu SY, Eun JW, Song J, Ahn YM, Kim SY, Lee SH, Park WS, Yoo NJ, Lee JY, Lee SN, Nam SW. Noh JH, et al. Among authors: ahn ym. Mol Cell Biochem. 2006 Aug;288(1-2):91-106. doi: 10.1007/s11010-006-9124-8. Epub 2006 Apr 7. Mol Cell Biochem. 2006. PMID: 16601922

6

Systemic cell-cycle suppression by Apicidin, a histone deacetylase inhibitor, in MDA-MB-435 cells.

Noh JH, Song JH, Eun JW, Kim JK, Jung KH, Bae HJ, Xie HJ, Ryu JC, Ahn YM, Wee SJ, Park WS, Lee JY, Nam SW. Noh JH, et al. Among authors: ahn ym. Int J Mol Med. 2009 Aug;24(2):205-26. doi: 10.3892/ijmm_00000224. Int J Mol Med. 2009. PMID: 19578794

7

Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.

Kim JK, Jung KH, Noh JH, Eun JW, Bae HJ, Xie HJ, Ahn YM, Ryu JC, Park WS, Lee JY, Nam SW. Kim JK, et al. Among authors: ahn ym. Int J Oncol. 2009 Dec;35(6):1257-64. Int J Oncol. 2009. PMID: 19885547

8

Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma.

Jung KH, Kim JK, Noh JH, Eun JW, Bae HJ, Xie HJ, Ahn YM, Park WS, Lee JY, Nam SW. Jung KH, et al. Among authors: ahn ym. J Cell Biochem. 2010 Jun 1;110(3):687-96. doi: 10.1002/jcb.22579. J Cell Biochem. 2010. PMID: 20512928

9

DBC1 does not function as a negative regulator of SIRT1 in liver cancer.

Bae HJ, Chang YG, Noh JH, Kim JK, Eun JW, Jung KH, Kim MG, Shen Q, Ahn YM, Kwon SH, Park WS, Lee JY, Nam SW. Bae HJ, et al. Among authors: ahn ym. Oncol Lett. 2012 Nov;4(5):873-877. doi: 10.3892/ol.2012.875. Epub 2012 Aug 23. Oncol Lett. 2012. PMID: 23162614 Free PMC article.

10

Characteristic molecular signatures of early exposure to volatile organic compounds in rat liver.

Kim JK, Eun JW, Bae HJ, Shen Q, Park SJ, Kim HS, Park S, Ahn YM, Park WS, Lee JY, Nam SW. Kim JK, et al. Among authors: ahn ym. Biomarkers. 2013 Dec;18(8):706-15. doi: 10.3109/1354750X.2013.847121. Epub 2013 Oct 21. Biomarkers. 2013. PMID: 24144218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

391 results

Search Page

Filters